AJP - Endo Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 282: E763-E769, 2002. First published December 4, 2001; doi:10.1152/ajpendo.00408.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/E763    most recent
00408.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watchorn, T. M.
Right arrow Articles by Ross, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watchorn, T. M.
Right arrow Articles by Ross, J. A.
Vol. 282, Issue 4, E763-E769, April 2002

Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes

T. M. Watchorn1, I. Waddell2, and J. A. Ross1

1 Molecular Immunology Group, Department of Clinical and Surgical Sciences, University of Edinburgh, Edinburgh EH3 9YW, United Kingdom; and 2 Cardiovascular and Gastrointestinal Discovery Department, AstraZeneca, Macclesfield SK10 4TG, United Kingdom

Proteolysis-inducing factor (PIF) is a novel sulfated glycoprotein initially identified as a protein capable of triggering muscle proteolysis during the process of cancer cachexia. Only skeletal muscle and liver exhibit substantial binding of PIF in adult tissue. Here, we demonstrate that PIF induces transcriptional regulation in both the liver endothelial cell line SK-HEP-1 and in human umbilical vein endothelial cells (HUVECs) but not in pulmonary artery endothelial cells. PIF differentially induces activation of nuclear factor-kappa B, resulting in the induction of proinflammatory cytokines [interleukin (IL)-8 and IL-6] and increased expression of the cell surface proteins intercellular adhesion molecule-1 and vascular cell adhesion molecule in SK-HEP-1 and HUVECs only. In addition, PIF induces the shedding of syndecans from the cell surface. Syndecans are involved in wound repair, metastasis of cancers, and embryonic development. These results suggest that PIF may play additional roles in the proinflammatory response observed in cancer cachexia but may also have a role without the cachectic process.

human umbilical vein endothelial cells; human pulmonary arterial endothelial cells; proteolysis-inducing factor; cachexia; inflammation


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. J. Tisdale
Mechanisms of Cancer Cachexia
Physiol Rev, April 1, 2009; 89(2): 381 - 410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. C. Cogger, I. M. Arias, A. Warren, A. C. McMahon, D. L. Kiss, V. M. Avery, and D. G. Le Couteur
The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells
Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G137 - G145.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Tisdale
Re: Wieland BM, et al. Is There a Human Homologue to the Murine Proteolysis-Inducing Factor?
Clin. Cancer Res., April 1, 2008; 14(7): 2245 - 2245.
[Full Text] [PDF]


Home page
FASEB J.Home page
M. GOTTE
Syndecans in inflammation
FASEB J, April 1, 2003; 17(6): 575 - 591.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online